Menu
Enrolling by invitation NCT07727603

Global AI Governance: Maturity and Implementation in Leading Hospitals for Responsible AI in Healthcare

— Observational AI Governance AI Maturity AI

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Survey and Interview.
Who it may be relevant to
Registry conditions: AI Governance, AI Maturity, AI. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Despite growing interest in artificial intelligence (AI) for Healthcare, successful implementation practices are still limited due to the complexity of developing and deploying AI systems. Effective AI governance is essential for safe, ethical and regulatory-compliant deployment of clinical AI. This study qualitatively evaluates both the maturity of AI implementation and the governance frameworks applied by leading "smart" hospitals. Findings will inform a consolidated governance toolkit for hospitals seeking responsible, scalable AI adoption.

Interventions

  • Other Survey and Interview
    Survey and interviews about AI Governance of the best smart hospitals globally

Primary outcome measures

  • Current AI Governance set-up [Time frame: Hospitals will have 6 weeks from the moment they receive the survey to complete it, and we anticipate needing about four months to conduct the interviews.]

Eligibility criteria

Inclusion criteria

  • Senior digital-health executives (e.g. Managing Director / Senior Management of Chief Information / Digital Officer or equivalent) designated by each hospital.
  • Written informed consent

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Netherlands · 1 center
  • Erasmus Medical Center — Rotterdam

Identifiers

NCT: NCT07727603 · 14381

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗